NCT06769386 Investigation of Muscle Oxygenation in Patients With Rheumatoid Arthritis
| NCT ID | NCT06769386 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kirsehir Ahi Evran Universitesi |
| Condition | Rheumatoid Arthritis |
| Study Type | OBSERVATIONAL |
| Enrollment | 68 participants |
| Start Date | 2025-01-25 |
| Primary Completion | 2026-01-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 68 participants in total. It began in 2025-01-25 with a primary completion date of 2026-01-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to investigate respiratory muscle strength, respiratory muscle endurance, muscle oxygenation, upper extremity and lower extremity exercise capacity in rheumatoid arthritis patients compared with healthy individuals.
Eligibility Criteria
Rheumatoid Arthritis Group Inclusion Criteria: * Patients diagnosed with rheumatoid arthritis, * The ages of 18-65 years, * Volunteer to participate in the study will be included in the study. Exclusion Criteria: * Serious cardiopulmonary, neurological, neuromuscular, orthopedic and other systemic diseases or other diseases affecting physical functions, * Participated in a planned exercise program in the last three months, * Cognitive impairment that will cause difficulty in understanding and following exercise test instructions, * Contraindications to exercise testing or exercise training according to the American Sports Medicine Association will not be included in the study. Control Group Inclusion Criteria: * The ages of 18-65 years, * Volunteer to participate in the study will be included in the study. Exclusion Criteria: * Diagnosed chronic or systemic disease, * Regular exercise (physical activity) 3 days a week, 150 minutes/week of moderate intensity * Smoking 10 packs x years or more, * Pneumonia or any acute infection, * Healthy individuals with any psychiatric disorder will not be included in the study.
Contact & Investigator
Başak KAVALCI KOL, PhD
PRINCIPAL INVESTIGATOR
Kirsehir Ahi Evran Universitesi
Frequently Asked Questions
Who can join the NCT06769386 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Rheumatoid Arthritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06769386 currently recruiting?
Yes, NCT06769386 is actively recruiting participants. Contact the research team at basak.kavalci@ahievran.edu.tr for enrollment information.
Where is the NCT06769386 trial being conducted?
This trial is being conducted at Kırşehir, Turkey (Türkiye).
Who is sponsoring the NCT06769386 clinical trial?
NCT06769386 is sponsored by Kirsehir Ahi Evran Universitesi. The principal investigator is Başak KAVALCI KOL, PhD at Kirsehir Ahi Evran Universitesi. The trial plans to enroll 68 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.